Tannin Capital »

Silverback Therapeutics shares owned by Tannin Capital

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Tannin Capital from 13F filings

Historical chart of Tannin Capital investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Tannin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Tannin Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $149k 19k 8.03

More positions owned by Tannin Capital

Global X Fds 1-3 Month T-bill (CLIP)
Berkshire Hathaway Inc Del Cl A (BRK.A)
JPMorgan Chase & Co. (JPM)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Goldman Sachs (GS)
Abbvie (ABBV)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Home Depot (HD)
Johnson & Johnson (JNJ)

View all positions for Tannin Capital

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Rubric Capital Management
Deerfield Management Company
Millennium Management
BlackRock
Standard Life Aberdeen
Sr One Capital Management
Vanguard Group
Franklin Resources
State Street Corporation
Vanguard Capital Management
UBS Group
Janney Montgomery Scott
Tyro Capital Management

View all funds holding Silverback Therapeutics